The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Pathogenesis of hepatitis B virus—related hepatocellular carcinoma: Old and new paradigms
Open accessAbstract
Chronic infection with the hepatitis B virus (HBV) is a major risk factor for development of hepatocellular carcinoma (HCC). The pathogenesis of cancer in HBV infection has been extensively analyzed, and multiple factors appear to play a role. A major factor is chronic inflammation and the effects of cytokines in the development of fibrosis and liver cell proliferation. Also important is the role of integration of HBV DNA into host cellular DNA, which, in some situations, acts to disrupt or promote expression of cellular genes that are important in cell growth and differentiation. In addition, expression of HBV proteins may have a direct effect on cellular functions, and some of these gene products can favor malignant transformation. Several HBV genes have been found in infected tissues more frequently than others, including truncated pre-S2/S, hepatitis B X gene, and a novel spliced transcript of HBV, referred to as the hepatitis B spliced protein. The proteins expressed from these integrated genes have been shown to have intracellular activities that may account for their association with HCC, including effects on cellular growth and apoptosis. Finally, some patients with HCC have no detectable hepatitis B surface antigen in serum but do have low levels of HBV DNA in serum and integrated molecules of HBV DNA in tissue. Occult HBV infection may account for a proportion of cases of HCC that occur in patients without serologic markers for hepatitis B and C and may be a cofactor in HCC in patients with chronic hepatitis C who have coexistent occult HBV infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ye, Q.-H., Qin, L.-X., Forgues, M., He, P., Kim, J. W., Peng, A. C., Simon, R., Li, Y., Robles, A. I., Chen, Y., et al. (2003) · Nature Medicine · doi:10.1038/nm843 · Cited by 850
Bréchot, C., Thiers, V., Kremsdorf, D., Nalpas, B., Pol, S., & Paterlini-Bréchot, P. (2001) · Hepatology · doi:10.1053/jhep.2001.25172 · Cited by 560
Self-citationTorbenson, M., & Thomas, D. L. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00345-6 · Cited by 533
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection
Pollicino, T., Squadrito, G., Cerenzia, G., Cacciola, I., Raffa, G., Craxı̀, A., Farinati, F., Missale, G., Smedile, A., Tiribelli, C., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.10.048 · Cited by 427
Calcium Signaling by HBx Protein in Hepatitis B Virus DNA Replication
Bouchard, M. J., Wang, L.-H., & Schneider, R. J. (2001) · Science · doi:10.1126/science.294.5550.2376 · Cited by 385
Paterlini-Bréchot, P., Saigo, K., Murakami, Y., Chami, M., Gozuacik, D., Mugnier, C., Lagorce, D., & Bréchot, C. (2003) · Oncogene · doi:10.1038/sj.onc.1206492 · Cited by 354
Self-citationRahmani, Z., Huh, K.-W., Lasher, R., & Siddiqui, A. (2000) · Journal of Virology · doi:10.1128/jvi.74.6.2840-2846.2000 · Cited by 319
Viruses, Immunity, and Cancer: Lessons from Hepatitis B
Chisari, F. V. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64980-2 · Cited by 304
Bréchot, C., Gozuacik, D., Murakami, Y., & Paterlini-Bréchot, P. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0321 · Cited by 276
Self-citationTu, H., Bonura, C., Giannini, C., Mouly, H., Soussan, P., Kew, M. C., Paterlini-Bréchot, P., Bréchot, C., & Kremsdorf, D. (2001) · PubMed · Cited by 185
Self-citation
Cited by
Marrero, J. A., Kulik, L. M., Sirlin, C. B., Zhu, A. X., Finn, R. S., Abecassis, M. M., Roberts, L. R., & Heimbach, J. K. (2018) · Hepatology · doi:10.1002/hep.29913 · Cited by 4,539
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
European Association for the Study of the Liver (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.010 · Cited by 2,925
Paradoxical roles of the immune system during cancer development
de Visser, K. E., Eichten, A., & Coussens, L. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1782 · Cited by 2,256
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets
Boyault, S., Rickman, D. S., de Reyniès, A., Balabaud, C., Rebouissou, S., Jeannot, E., Hérault, A., Saric, J., Belghiti, J., Franco, D., et al. (2007) · Hepatology · doi:10.1002/hep.21467 · Cited by 1,258
Statements from the Taormina expert meeting on occult hepatitis B virus infection
Raimondo, G., Allain, J.-P., Brunetto, M. R., Buendia, M.-A., Chen, D.-S., Colombo, M., Craxì, A., Donato, F., Ferrari, C., Gaeta, G. B., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.07.014 · Cited by 833
IMMUNOBIOLOGY AND PATHOGENESIS OF VIRAL HEPATITIS
Guidotti, L. G., & Chisari, F. V. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100230 · Cited by 811
Human Viral Oncogenesis: A Cancer Hallmarks Analysis
Mesri, E. A., Feitelson, M. A., & Munger, K. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.02.011 · Cited by 650
Update of the statements on biology and clinical impact of occult hepatitis B virus infection
Raimondo, G., Locarnini, S., Pollicino, T., Levrero, M., Zoulim, F., Lok, A. S., Allain, J.-P., Berg, T., Bertoletti, A., Brunetto, M. R., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.03.034 · Cited by 572
Occult hepatitis B virus infection
Raimondo, G., Pollicino, T., Cacciola, I., & Squadrito, G. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2006.10.007 · Cited by 543
HBV DNA Integration: Molecular Mechanisms and Clinical Implications
Tu, T., Budzinska, M., Shackel, N., & Urban, S. (2017) · Viruses · doi:10.3390/v9040075 · Cited by 447
Pathogenesis of hepatitis B virus infection
Chisari, F. V., Isogawa, M., & Wieland., S. F. (2010) · Pathologie Biologie · doi:10.1016/j.patbio.2009.11.001 · Cited by 414
Viruses associated with human cancer
McLaughlin-Drubin, M. E., & Munger, K. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2007.12.005 · Cited by 406
New therapies for hepatocellular carcinoma
Avila, M. A., Berasain, C., Sangro, B., & Prieto, J. (2006) · Oncogene · doi:10.1038/sj.onc.1209550 · Cited by 383
Jiang, R., Tang, J., Chen, Y., Deng, L., Ji, J., Xie, Y., Wang, K., Jia, W., Chu, W.-M., & Sun, B. (2017) · Nature Communications · doi:10.1038/ncomms15129 · Cited by 343
Seitz, H. K., & Stickel, F. (2006) · Biological Chemistry · doi:10.1515/bc.2006.047 · Cited by 325
Aberrant Epigenetic Modifications in Hepatocarcinogenesis Induced by Hepatitis B Virus X Protein
Park, I. Y., Sohn, B. H., Yu, E., Suh, D. J., Chung, Y., Lee, J., Surzycki, S. J., & Lee, Y. I. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.01.034 · Cited by 320
Genetic profiling of hepatocellular carcinoma using next-generation sequencing
Schulze, K., Nault, J.-C., & Villanueva, A. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.035 · Cited by 317
Hepatitis B‐related hepatocellular carcinoma: epidemiological characteristics and disease burden
Nguyen, V. T. T., Law, M. G., & Dore, G. J. (2009) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2009.01117.x · Cited by 302
Mak, L.-Y., Wong, D. K.-H., Pollicino, T., Raimondo, G., Hollinger, F. B., & Yuen, M.-F. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.05.042 · Cited by 223
Leptin in hepatocellular carcinoma
Wang, S.-N. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i46.5801 · Cited by 59
Metadata
- Authors
- Bréchot, C.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2004-11
- Volume
- 127
- Issue
- 5
- Pages
- S56-S61
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2071019693
- Cited by
- 438
- References
- 21
- FWCI
- 17.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.